英文名稱
Desoxo-palbociclib
8-環戊基-5-甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-6- 乙烯基吡啶并[2,3-d]嘧啶-7(8H)-酮
Smiles Code
CC1=C(C=C)C(=O)N(C2CCCC2)c3nc(Nc4ccc(cn4)N5CCNCC5)ncc13
純度
>95% (HPLC)
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
DMSO (Very Slightly, Heated)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Desoxo-palbociclib is a derivative compound of Palbociclib (P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.